| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/04/2001 | EP0902777B1 D-mannitol and its preparation |
| 07/04/2001 | EP0828554B1 Alkylpolyglycosides-based emulsifying composition and uses thereof |
| 07/04/2001 | EP0814776B1 Topically applied pharmaceutical composition, method of preparing it and its use |
| 07/04/2001 | EP0760651B1 Pharmaceutical compositions derived from microelmulsion-based gels, method for their preparation and new microemulsion-based gels |
| 07/04/2001 | EP0727983B1 Process for preparing a clodronate preparation |
| 07/04/2001 | EP0706370B1 Stable topical retinoid compositions |
| 07/04/2001 | CN1302304A AZT derivatives exhibiting spermicidal and anti-viral activity |
| 07/04/2001 | CN1302215A Local preparation containing poloxamer and other microbe killing agent and applicator |
| 07/04/2001 | CN1302203A Spray-dried powders with high edible-oil loading based on non-hydrolyzed gelatin and method of making such spry-dried tablettable powders |
| 07/04/2001 | CN1302202A Opthalmic solution comprising glycogen |
| 07/04/2001 | CN1302201A Ophthalmic compositions containing galactomannan polymers and borate |
| 07/04/2001 | CN1302183A Xylitol compositions for treating upper respiratory conditions |
| 07/04/2001 | CN1301555A Medicine for curing appendicitis and its preparing method |
| 07/04/2001 | CN1301547A Analgesic plaster for osteoarthritis |
| 07/04/2001 | CN1301538A Melanin cell growth promotor for external use for skin and producing method thereof |
| 07/04/2001 | CN1301534A Stable slow-releasing oral administration composition |
| 07/04/2001 | CN1067915C Production of fine particle dye or drug preparation |
| 07/04/2001 | CN1067902C Decrustation ointment for burn and its preparing process |
| 07/04/2001 | CN1067901C Drug for curing migraine and its preparing method |
| 07/04/2001 | CN1067900C Medicine bolus for hepatitis B and its preparing method |
| 07/04/2001 | CN1067898C Blood platelet regenerating pills and its preparation method |
| 07/04/2001 | CN1067897C Medicine for cleaning scar and stain on skin |
| 07/04/2001 | CN1067894C Traditional Chinese medicine capsule with tonifying kidney function and its preparing method |
| 07/04/2001 | CN1067891C Traditional Chinese medicine for curing cerebral thrambus |
| 07/04/2001 | CN1067886C Preparation of scald ointment |
| 07/04/2001 | CN1067880C Pingyasan for hypertension |
| 07/04/2001 | CN1067879C Preparation for curing dermatomycosis |
| 07/04/2001 | CN1067875C Estradiol weekly-acting percutaneous absorption adhesive plaster |
| 07/04/2001 | CN1067874C Traditional Chinese medicine plaster and its preparation method |
| 07/03/2001 | US6255502 Pharmaceutical composition containing acid addition salt of basic drug |
| 07/03/2001 | US6255481 Treating aqueous suspension of anhydrous nevirapine with hydrochloric acid then treating with sodium hydroxide yields the free base as a precipitate/hemihydrate which is then filtered from solution and water washed |
| 07/03/2001 | US6255457 Immunoglobulin for use as diagnositic tool and in preferential drug delivery |
| 07/03/2001 | US6255421 Non-aqueous, heterogeneous polymerization process and reaction product obtained thereby |
| 07/03/2001 | US6255325 Chronic, bolus administration of D-threo methylphenidate |
| 07/03/2001 | US6255299 Opthalmic gel composition and method of treating eye infections |
| 07/03/2001 | US6255294 Absorption by mucous membrane |
| 07/03/2001 | US6255290 Reducing sensitivity to skin cancer; topical administering of nucleotide |
| 07/03/2001 | US6255284 Pharmaceutical composition |
| 07/03/2001 | US6255281 Complexing uteroglobin to fibronectin |
| 07/03/2001 | US6254893 Calcium-based ophthalmic composition including a hydrophobic carrier, such as petrolatum, and a calcium salt, sufficiently viscous to prevent dripping or running after application to the skin adjacent the eyelids |
| 07/03/2001 | US6254892 Pellet formulations |
| 07/03/2001 | US6254891 Coated on sugar/starch seeds as a blend of both an immediate release and a controlled release form |
| 07/03/2001 | US6254890 A nanosphere of biodegradable polymer containing and releasing nucleic acids; gene therapy, antisense therapy,to study cell differentiation, growth and carcinogenic transformation,animal models for human disease |
| 07/03/2001 | US6254889 Solid dispersion dosage form of amorphous xanthine derivative and enteric-coating polymer |
| 07/03/2001 | US6254888 Covering any embossed or printed matter or colored coating by applying nt a sugar based coating sufficient to obscure any identifying indicia without compromising the stability or releasability of the drug |
| 07/03/2001 | US6254887 Controlled release tramadol |
| 07/03/2001 | US6254886 Multilayer tablet |
| 07/03/2001 | US6254885 Containing: cyclosporin, ethanol or propylene glycol, non-ionic polyoxyalkylene surfactant, cosolvent; high bioavailability, used in immuno-suppressive therapy |
| 07/03/2001 | US6254884 Somatotropin compositions mixed with vitamins |
| 07/03/2001 | US6254883 Composition for transdermal delivery of drugs |
| 07/03/2001 | US6254882 Ion exchanging of drug delivery |
| 07/03/2001 | US6254881 Treatment of infections in mammary glands |
| 07/03/2001 | US6254879 Quaternariumaminoethylphosphates |
| 07/03/2001 | US6254866 Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract |
| 07/03/2001 | US6254860 Ocular treatment using cyclosporin-A derivatives |
| 07/03/2001 | US6254854 Porous particles for deep lung delivery |
| 07/03/2001 | US6254853 Drugs with carriers |
| 07/03/2001 | US6254558 Method for producing a therapeutic system in the form of plaster |
| 07/03/2001 | US6253762 Metered dose inhaler for fluticasone propionate |
| 07/03/2001 | US6253463 Method of spray drying |
| 07/03/2001 | CA2166891C Method for making freeze dried drug dosage forms |
| 07/03/2001 | CA2141704C Concentrated aqueous argatroban solutions |
| 07/03/2001 | CA2132512C Bioadhesive pharmaceutical composition used for the controlled release of active ingredient |
| 07/03/2001 | CA2116563C Dry gel pharmaceutical composition |
| 07/03/2001 | CA2107466C Low density microspheres and their use as contrast agents for computed tomography |
| 07/03/2001 | CA2098108C Water dispersible tablets |
| 07/03/2001 | CA2077641C Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief |
| 07/03/2001 | CA2073680C Liposome composition |
| 06/28/2001 | WO2001047230A1 Bidding for telecommunications traffic |
| 06/28/2001 | WO2001046150A2 Quinolone compounds for use in treating viral infections |
| 06/28/2001 | WO2001046132A1 Use of biologically active vitamin d compounds for the prevention and treatment of inflammatory bowel disease |
| 06/28/2001 | WO2001045835A1 Sensitive substance encapsulation |
| 06/28/2001 | WO2001045789A2 Ingestible device for the release of substances at distinct locations in the alimentary canal |
| 06/28/2001 | WO2001045743A2 Use of an enzyme to improve the resorption of medicaments in the tissue |
| 06/28/2001 | WO2001045742A1 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 06/28/2001 | WO2001045741A2 Methods for preparing pharmaceutical formulations |
| 06/28/2001 | WO2001045731A1 Particulate drug-containing products and method of manufacture |
| 06/28/2001 | WO2001045713A1 Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method |
| 06/28/2001 | WO2001045710A1 Pharmaceutical composition containing [1-{[1-(1,3-benzodioxol-5-ylmethyl)-1h-imidazol-5-yl]methyl}-4-(1-naphthyl)-1h-pyrrol-3-yl](4-methyl-1-piperazinyl)methanone |
| 06/28/2001 | WO2001045706A1 Dual-release compositions of a cyclooxygenase-2- inhibitor |
| 06/28/2001 | WO2001045705A1 Sustained-release formulation of a cyclooxygenase-2 inhibitor |
| 06/28/2001 | WO2001045695A2 Calcium formate for use as a phosphorus binder and a dietary supplement |
| 06/28/2001 | WO2001045691A2 Method of treating gastrointestinal tract disease with purinergic receptor agonists |
| 06/28/2001 | WO2001045679A2 Use of chemotherapeutic agents for topical treatment |
| 06/28/2001 | WO2001045677A1 Process for producing nanometer particles by fluid bed spray-drying |
| 06/28/2001 | WO2001045676A2 Extended release oral dosage composition |
| 06/28/2001 | WO2001045675A2 Valve for osmotic devices |
| 06/28/2001 | WO2001045674A1 Process for producing nanometer particles by fluid bed spray-drying |
| 06/28/2001 | WO2001045673A1 Cyclosporin(s)-containing hypertonic pharmaceutical preparation for the application for neurological diseases and as a neuroprotective |
| 06/28/2001 | WO2001045672A2 Mixed structures resulting from the incorporation of a biological macromolecule in a liquid crystal phase of amphiphiles |
| 06/28/2001 | WO2001045671A2 Suspension comprising oxcarbazepine |
| 06/28/2001 | WO2001045670A2 A stable immunogenic composition for frozen storage |
| 06/28/2001 | WO2001045668A2 Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine |
| 06/28/2001 | WO2001045667A2 Water-soluble powders for oral solution and use thereof |
| 06/28/2001 | WO2001045665A1 Skin preparations for external use |
| 06/28/2001 | WO2001045661A2 Cosmetic and/or pharmaceutical preparations |
| 06/28/2001 | WO2001045645A1 Chitosan biopolymer for the topical delivery of active agents |
| 06/28/2001 | WO2001045642A2 Pulmonary delivery of ribavirin or levovirin™ for systemic and quasi-systemic treatment of disease |
| 06/28/2001 | WO2001045640A2 Barrier-forming composition |
| 06/28/2001 | WO2001045635A1 Method for manufacturing seamless capsule |